Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

BNT162b2 (2025/2026 formulation) - Phase 3 | BNTX Pipeline | CatalystAlert

BNT162b2 (2025/2026 formulation)

Phase 3

BioNTech SE (BNTX)

61%

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Oct 30

BNTX⭐Phase 3Phase 3

BNT162b2 (2025/2026 formulation) Phase 3 Results Expected

BNT162b2 (2025/2026 formulation) • COVID-19

Drug Information

Target Indication

COVID-19

Clinical Trial

Last updated: 12/4/2025

Developer

BNTX

BioNTech SE

Biotechnology•Europe•NASDAQ